진매트릭스

109820KOSDAQ자연과학 및 공학 연구개발업

42.5 / 100

Reference Date: 2026-04-13

Financial Score17.0 / 40

News Sentiment12.5 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 8.6% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

JinMatrix is a biotechnology company established in 2000, specializing in the development of pharmaceuticals and diagnostic kits using proprietary technologies such as C-Tag and Encleap. Its flagship product, NeoPlex, enables the simultaneous detection of multiple pathogens, including sexually transmitted infections, tuberculosis, and HPV, and the company is expanding into global molecular diagnostics markets, particularly in Europe.

Number of Employees

69people

Average Salary

47.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 120.074.0Point

PBR

2.35Industry Average 3.825.5Point

Lower than industry avg (good)

ROE

-10.00Industry Average -32.113.5Point

Well below industry avg

Debt Ratio

29.33Industry Average 7.520.0Point

3.9x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲4.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲47.1% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.5% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (7%, downtrend)

Current 2,010Won52-week high 3,34552-week low 1,899

1-month return1.0Point

1m -8.64% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral정기주주총회결과2026-03-26
Neutral감사보고서제출2026-03-18
Neutral사업보고서 (2025.12)2026-03-18